Form 4 for CRM Salesforce
Accepted 2024-10-22 00:00:00 ET · period of report 2024-10-22 · accession 0001127602-24-025869 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-10-22 | 2024-10-22 | CRM | Millham Brian | Pres, COO | M - OptEx | $206.73 | +6,161 | 2,038 | New | +$1.27M |
| D | 2024-10-22 | 2024-10-22 | CRM | Millham Brian | Pres, COO | S - Sale+OE | $289.75 | -6,161 | 0 | -100% | -$1.79M |
| DM | 2024-10-22 | 2024-10-22 | CRM | Millham Brian | Pres, COO | M - OptEx | $0.00 | -6,161 | 10.1K | -38% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-22 | M | A | 2,017 | $215.17 | 4,055 | D | — | — | |
| 2 | Common | Common Stock | 2024-10-22 | M | A | 2,106 | $218.21 | 6,161 | D | — | — | |
| 3 | Common | Common Stock | 2024-10-22 | M | A | 2,038 | $186.51 | 2,038 | D | — | — | |
| 4 | Common | Common Stock | 2024-10-22 | S | D | 6,161 | $289.75 | 0 | D | — | — | |
| 5 | Derivative | Non-qualified Stock Option (Right to Buy) | 2024-10-22 | M | D | 2,038 | $0.00 | 59,094 | D | $186.51 · 2024-03-22 to 2030-03-22 | 2,038 Common Stock | (F2) Option is exercisable and vests over four years at the rate of 25% on March 22, 2024, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months. |
| 6 | Derivative | Non-qualified Stock Option (Right to Buy) | 2024-10-22 | M | D | 2,106 | $0.00 | 35,814 | D | $218.21 · 2023-03-22 to 2029-03-22 | 2,106 Common Stock | (F4) Option is exercisable and vests over four years at the rate of 25% on March 22, 2023, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months. |
| 7 | Derivative | Non-qualified Stock Option (Right to Buy) | 2024-10-22 | M | D | 2,017 | $0.00 | 10,090 | D | $215.17 · 2022-03-22 to 2028-03-22 | 2,017 Common Stock | (F3) Option is exercisable and vests over four years at the rate of 25% on March 22, 2022, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months. |